Home > Oncology > COVID-19 has disrupted cancer care, particularly among minority groups

COVID-19 has disrupted cancer care, particularly among minority groups

Conference
ESMO 2020
Reuters Health - 22/09/2020 - The COVID-19 pandemic has led to significant disruptions in routine cancer care, especially among racial and ethnic minority groups, according to the COVID-19 and Cancer Outcomes Study (CCOS). "Unfortunately, the pandemic has further exacerbated existing health inequities in its impact upon the delivery of cancer care," Dr. Deborah Doroshow, with the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, in New York City, told Reuters Heath by phone. Minority patients with cancer have suffered a "disproportionate burden" of care disruptions due to the COVID-19 pandemic, "and interventions aimed to narrow these disparities in care delivery are needed," she added. The findings were presented September 20 at the European Society of Medical Oncology (ESMO) Virtual Congress 2020. The CCOS cohort includes 2,365 cancer outpatients (median age 64, 46% women) from Mount Sinai Hospital in New York and Dana-Farber Cancer In...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on